In a multicentre analysis of 21 HVAD thrombosis patients, t-PA therapy was associated with an effectiveness of only 48% and a high rate of complications such as haemorrhagic stroke (21%) and death (10%) [9]. The gene discussed is PLAT; the disease is deep vein thrombosis.